European patent applications drop in 2009
This article was originally published in Scrip
Despite the first drop in 20 years in the number of European patents filed last year, the number filed by the medical technology sector – responsible for the largest number of applications – remains stable, says the European Patent Office (EPO).
You may also be interested in...
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.
To maintain high prices and avoid access restrictions, companies marketing advanced therapies will have to show payers that their products save money elsewhere in the healthcare system.